The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.

The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.

The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.

When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.

Share:
More In Business
Stretching Your Dollar: Expert Holiday Design Tips on a Budget
The holiday season is underway and it's a good time to put your Christmas tree up if you haven't already. But making your home festive can be costly. Cameron Forbes, founder of Forbes Functions, joined Cheddar News to provide tips for decorating on a dime.
Regulators Investigating Chevy Volts
Federal regulators are investigating Chevrolet Volt hybrid cars after some drivers reported issues including sudden power loss and failure to restart.
Celebrating the Holidays With Build-A-Bear Workshop
Build-A-Bear Workshop has been one of the most recognizable and beloved toy brands in the world since opening in 1997. Sharon Price John, CEO of Build-A-Bear Workshop, spoke with Cheddar News about its plans for the holiday season this year as well as the company's first animated feature film.
Stocks Flat Ahead of Fed Chair Comments
Stocks were generally flat after the opening bell on Friday ahead of Federal Reserve Chair Jerome Powell's comments in a speech at Spelman College later. Investors are growing optimistic that the central bank is done raising rates and may start cutting next year.
Load More